A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial
- 1.2k Downloads
Dietary recommendations for treating type 2 diabetes are unclear but a trend towards recommending a diet reduced in carbohydrate content is acknowledged. We compared a carbohydrate-reduced high-protein (CRHP) diet with an iso-energetic conventional diabetes (CD) diet to elucidate the effects on glycaemic control and selected cardiovascular risk markers during 6 weeks of full food provision of each diet.
The primary outcome of the study was change in HbA1c. Secondary outcomes reported in the present paper include glycaemic variables, ectopic fat content and 24 h blood pressure. Eligibility criteria were: men and women with type 2 diabetes, HbA1c 48–97 mmol/mol (6.5–11%), age >18 years, haemoglobin >6/>7 mmol/l (women/men) and eGFR >30 ml min−1 (1.73 m)−2. Participants were randomised by drawing blinded ballots to 6 + 6 weeks of an iso-energetic CRHP vs CD diet in an open label, crossover design aiming at body weight stability. The CRHP/CD diets contained carbohydrate 30/50 energy per cent (E%), protein 30/17E% and fat 40/33E%, respectively. Participants underwent a meal test at the end of each diet period and glycaemic variables, lipid profiles, 24 h blood pressure and ectopic fat including liver and pancreatic fat content were assessed at baseline and at the end of each diet period. Data were collected at Copenhagen University Hospital, Bispebjerg and Copenhagen University Hospital, Herlev.
Twenty-eight participants completed the study. Fourteen participants carried out 6 weeks of the CRHP intervention followed by 6 weeks of the CD intervention, and 14 participants received the dietary interventions in the reverse order. Compared with a CD diet, a CRHP diet reduced the primary outcome of HbA1c (mean ± SEM: −6.2 ± 0.8 mmol/mol (−0.6 ± 0.1%) vs −0.75 ± 1.0 mmol/mol (−0.1 ± 0.1%); p < 0.001). Nine (out of 37) pre-specified secondary outcomes are reported in the present paper, of which five were significantly different between the diets, (p < 0.05); compared with a CD diet, a CRHP diet reduced the secondary outcomes (mean ± SEM or medians [interquartile range]) of fasting plasma glucose (−0.71 ± 0.20 mmol/l vs 0.03 ± 0.23 mmol/l; p < 0.05), postprandial plasma glucose AUC (9.58 ± 0.29 mmol/l × 240 min vs 11.89 ± 0.43 mmol/l × 240 min; p < 0.001) and net AUC (1.25 ± 0.20 mmol/l × 240 min vs 3.10 ± 0.25 mmol/l × 240 min; p < 0.001), hepatic fat content (−2.4% [−7.8% to −1.0%] vs 0.2% [−2.3% to 0.9%]; p < 0.01) and pancreatic fat content (−1.7% [−3.5% to 0.6%] vs 0.5% [−1.0% to 2.0%]; p < 0.05). Changes in other secondary outcomes, i.e. 24 h blood pressure and muscle-, visceral- or subcutaneous adipose tissue, did not differ between diets.
A moderate macronutrient shift by substituting carbohydrates with protein and fat for 6 weeks reduced HbA1c and hepatic fat content in weight stable individuals with type 2 diabetes.
The study was funded by grants from Arla Food for Health; the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen; the Department of Clinical Medicine, Aarhus University; the Department of Nutrition, Exercise and Sports, University of Copenhagen; and Copenhagen University Hospital, Bispebjerg.
KeywordsCarbohydrate restriction Cardiovascular disease Dietary intervention Ectopic fat deposition Glycaemic control Metabolism Non-alcoholic fatty liver disease Nutritional therapy Type 2 diabetes mellitus Weight stability
Energy per cent
Mixed meal test
Non-alcoholic fatty liver disease
Subcutaneous adipose tissue
Total energy expenditure
Visceral adipose tissue
The authors sincerely thank the study participants for their efforts in making this study possible. Further, we thank the kitchen personnel at the Department of Nutrition, Exercise and Sports, University of Copenhagen. Preliminary results from the present study were presented by MJS and AS as poster presentations at the 77th Scientific Session of the ADA, 2017, and at the 54th Annual Meeting of the EASD, 2018.
MJS and AS conducted the study, acquired and analysed the data, and drafted the manuscript. ADP and MNT contributed to acquisition of data. EC produced and analysed magnetic resonance data and contributed to drafting of the manuscript. AA, JF, JJH, HST, SM and TML contributed to the conception and the design of the study and contributed to the production and the interpretation of data. In addition, TML supervised the food production and distribution. SBH and TK conceived and designed the study, obtained funding, supervised the study and contributed to interpretation of data. TK is the guarantor of the manuscript. All authors critically reviewed the manuscript and approved the version to be published.
The study was funded by grants from: Arla Food for Health; the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen; the Department of Clinical Medicine, Aarhus University; the Department of Nutrition, Exercise and Sports, University of Copenhagen; and Copenhagen University Hospital, Bispebjerg. Dietary ingredients were partly provided by Arla Foods, JAN Import A/S, Royal Greenland and Danish Crown. The study sponsors, Arla Food for Health, Arla Foods, JAN Import A/S, Royal Greenland and Danish Crown, were informed, but not involved in the design of the study; the collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication. Co-authors from the University of Copenhagen and Aarhus University were involved in the study, as detailed in the contribution statement.
Duality of interest
AA is a member of advisory boards/consultant for: BioCare Copenhagen, Denmark; the Dutch Beer Institute, the Netherlands; Gelesis, USA; Groupe Éthique et Santé, France; McCain Foods Limited, USA; Navamedic, Denmark; Novo Nordisk, Denmark; Pfizer, USA; Saniona, Denmark; Weight Watchers, USA; and is a recipient of travel grants and honoraria as speaker for a wide range of Danish and international concerns. AA is co-owner and a member of the board of the consultancy company Dentacom ApS, Denmark; co-founder and co-owner of UCPH spin-outs Mobile Fitness A/S, Flaxslim ApS and Personalized Weight Management Research Consortium ApS (Gluco-diet.dk). AA is co-inventor of a number of patents owned by UCPH, in accordance with Danish law. AA is co-author of a number of diet and cookery books, including books on personalised diet. AA is not an advocate or activist for specific diets, and is not strongly committed to any specific diet, e.g. veganism, Atkins diet, gluten-free diet, high-animal protein diet or dietary supplements. TML is an advisor for ‘Sense’ diet programme. None of the other authors have conflicts of interest to declare.
- 5.Davies MJ, D’Alessio DA, Fradkin J et al (2018) Management of hyperglycemia in type 2 diabetes, 2018.A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 61(12):2461–2498. https://doi.org/10.1007/s00125-018-4729-5 CrossRefGoogle Scholar
- 8.Coulston AM, Hollenbeck CB, Swislocki AL, Chen YD, Reaven GM (1987) Deleterious metabolic effects of high-carbohydrate, sucrose-containing diets in patients with non-insulin-dependent diabetes mellitus. Am J Med 82(2):213–220. https://doi.org/10.1016/0002-9343(87)90058-1 CrossRefPubMedGoogle Scholar
- 10.Samkani A, Skytte MJ, Anholm C et al (2018) The acute effects of dietary carbohydrate reduction on postprandial responses of non-esterified fatty acids and triglycerides: a randomized trial. Lipids Health Dis 17(1):295. https://doi.org/10.1186/s12944-018-0953-8 CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Nielsen S, Hensrud DD, Romanski S, Levine JA, Burguera B, Jensen MD (2000) Body composition and resting energy expenditure in humans: role of fat, fat-free mass and extracellular fluid. Int J Obes Relat Metab Disord 24(9):1153–1157. https://doi.org/10.1038/sj.ijo.0801317 CrossRefPubMedGoogle Scholar
- 20.Fonvig CE, Bille DS, Chabanova E, Nielsen TR, Thomsen HS, Holm JC (2012) Muscle fat content and abdominal adipose tissue distribution investigated by magnetic resonance spectroscopy and imaging in obese children and youths. Pediatr Rep 4(1):e11. https://doi.org/10.4081/pr.2012.e11 CrossRefPubMedPubMedCentralGoogle Scholar
- 29.van Zuuren EJ, Fedorowicz Z, Kuijpers T, Pijl H (2018) Effects of low-carbohydrate- compared with low-fat-diet interventions on metabolic control in people with type 2 diabetes: a systematic review including GRADE assessments. Am J Clin Nutr 108(2):300–331. https://doi.org/10.1093/ajcn/nqy096 CrossRefPubMedGoogle Scholar
- 31.Meng Y, Bai H, Wang S, Li Z, Wang Q, Chen L (2017) Efficacy of low carbohydrate diet for type 2 diabetes mellitus management: a systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract 131:124–131. https://doi.org/10.1016/j.diabres.2017.07.006 CrossRefPubMedGoogle Scholar
- 34.Pramfalk C, Pavlides M, Banerjee R et al (2016) Fasting plasma insulin concentrations are associated with changes in hepatic fatty acid synthesis and partitioning prior to changes in liver fat content in healthy adults. Diabetes 65(7):1858–1867. https://doi.org/10.2337/db16-0236 CrossRefPubMedGoogle Scholar
- 35.Schwarz JM, Linfoot P, Dare D, Aghajanian K (2003) Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 77(1):43–50. https://doi.org/10.1093/ajcn/77.1.43 CrossRefPubMedGoogle Scholar
- 36.Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115(5):1343–1351. https://doi.org/10.1172/JCI23621 CrossRefPubMedPubMedCentralGoogle Scholar
- 38.Szczepaniak LS, Nurenberg P, Leonard D et al (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288(2):E462–E468. https://doi.org/10.1152/ajpendo.00064.2004 CrossRefPubMedGoogle Scholar
- 39.van Werven JR, Marsman HA, Nederveen AJ et al (2010) Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology 256(1):159–168. https://doi.org/10.1148/radiol.10091790 CrossRefPubMedGoogle Scholar
- 40.Nasr P, Forsgren MF, Ignatova S et al (2017) Using a 3% proton density fat fraction as a cut-off value increases sensitivity of detection of hepatic steatosis, based on results from histopathology analysis. Gastroenterology 153(1):53–55. https://doi.org/10.1053/j.gastro.2017.03.005 CrossRefPubMedGoogle Scholar
- 41.Seppala-Lindroos A, Vehkavaara S, Hakkinen AM et al (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87(7):3023–3028. https://doi.org/10.1210/jcem.87.7.8638 CrossRefPubMedGoogle Scholar
- 43.Heni M, Machann J, Staiger H et al (2010) Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev 26(3):200–205. https://doi.org/10.1002/dmrr.1073 CrossRefPubMedGoogle Scholar
- 49.Tay J, Thompson CH, Luscombe-Marsh ND et al (2015) Long-term effects of a very low carbohydrate compared with a high carbohydrate diet on renal function in individuals with type 2 diabetes: a randomized trial. Medicine 94(47):e2181. https://doi.org/10.1097/MD.0000000000002181 CrossRefPubMedPubMedCentralGoogle Scholar
- 50.Tay J, Thompson CH, Luscombe-Marsh ND et al (2018) Effects of an energy-restricted low-carbohydrate, high unsaturated fat/low saturated fat diet versus a high-carbohydrate, low-fat diet in type 2 diabetes: a 2-year randomized clinical trial. Diabetes Obes Metab 20(4):858–871. https://doi.org/10.1111/dom.13164 CrossRefPubMedGoogle Scholar